Seontae Kim

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Event-based surveillance in Republic of Korea: assessment of the effectiveness of Epidemic Intelligence from Open Sources.

Event-based surveillance in Republic of Korea: assessment of the effectiveness of Epidemic Intelligence from Open Sources.

Journal: Western Pacific surveillance and response journal : WPSAR

Published: August 08, 2025

Image quality assessment and white matter hyperintensity quantification in two accelerated high-resolution 3D FLAIR techniques: Wave-CAIPI and deep learning-based SPACE.

Image quality assessment and white matter hyperintensity quantification in two accelerated high-resolution 3D FLAIR techniques: Wave-CAIPI and deep learning-based SPACE.

Journal: Clinical radiology

Published: October 02, 2024

Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea.

Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea.

Journal: Osong public health and research perspectives

Published: July 08, 2024

Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea.

Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea.

Journal: Osong public health and research perspectives

Published: March 20, 2024

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea.

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea.

Journal: Osong public health and research perspectives

Published: May 14, 2023

Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over.

Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over.

Journal: Vaccine

Published: May 10, 2023

Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years.

Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years.

Journal: Osong public health and research perspectives

Published: August 16, 2022

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea.

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea.

Journal: Epidemiology and health

Published: August 04, 2022

Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea.

Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea.

Journal: Clinical and experimental pediatrics

Published: June 08, 2022

Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea.

Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea.

Journal: Osong public health and research perspectives

Published: April 08, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026